RESEARCHER PROFILE
Beth Y. Karlan
← Back to University of California, Los Angeles
B
University of California, Los Angeles
Beth Y. Karlan works in Ovarian cancer diagnosis and treatment, BRCA gene mutations in cancer, PARP inhibition in cancer therapy, Genetic Associations and Epidemiology, Endometrial and Cervical Cancer Treatments. Recorded institutional associations include University of California, Los Angeles, UCLA Jonsson Comprehensive Cancer Center.
1,115Publications
83,649Citations
128H-index
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
The Immune Landscape of Cancer
2018 · 5,739 citationsAn Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
2018 · 3,681 citationsThe repertoire of mutational signatures in human cancer
2020 · 3,468 citationsOncogenic Signaling Pathways in The Cancer Genome Atlas
2018 · 3,175 citationsPan-cancer analysis of whole genomes
2020 · 3,054 citationsCell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer
2018 · 2,521 citationsComprehensive Characterization of Cancer Driver Genes and Mutations
2018 · 2,298 citationsMachine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation
2018 · 2,172 citationsIntegrated genomic and molecular characterization of cervical cancer
2017 · 1,564 citationsRethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
2015 · 1,367 citationsOvarian cancer
2016 · 1,264 citationsGenomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas
2018 · 1,136 citationsGenetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
2021 · 1,112 citationsSecondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers
2008 · 1,083 citationsComprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas
2017 · 1,063 citationsGenomic and Functional Approaches to Understanding Cancer Aneuploidy
2018 · 1,062 citationsThe evolutionary history of 2,658 cancers
2020 · 1,046 citationsSpatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images
2018 · 1,022 citationsCommon Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk
2015 · 902 citationsComprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients
2018 · 897 citationsPatterns of somatic structural variation in human cancer genomes
2020 · 866 citationsScalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines
2018 · 852 citationsPathogenic Germline Variants in 10,389 Adult Cancers
2018 · 833 citationsThe Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma
2018 · 770 citationsThe Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma
2018 · 734 citations
